Wednesday, February 08, 2012
Home HAAD News Events Feedback Contact Us Site Map
  Search
Home

Poll
The Poison and Drug Information Center serves a vital and necessary function?



Submit Survey  View Results
PDIC ADVERTISEMENTS

Latest News

On July 13 , 2011 - United States FDA and Global Wellness, LLC. Hollywood, FL
expanded its voluntary nationwide recall of VIA XTREME ULTIMATE SEXUAL ENHANCER DIETARY SUPPLEMENT FOR MEN to the consumer level to include lot A032111. The product was distributed throughout the U.S. Puerto Rico, Barbados, and Canada to internet and retail consumers. The product is distributed as a bottle containing six (6) blue colored capsules per package. The label on the packaging lists the company name Global
Wellness, LLC, Hollywood Florida.
Lot numbers #809013, 806030, and A032111 are covered in this recall.

On March 4, 2011 FDA notified healthcare professionals and patients of an increased risk of development of cleft lip and/or cleft palate (oral clefts) in infants born to women treated with Topamax (topiramate) during pregnancy.

On March 8, 2011 FDA notified healthcare professionals of serious health problems that have been reported in premature babies receiving Kaletra (lopinavir/ritonavir) oral solution.

Events